EN | RU
EN | RU

Help Support

Back

Efficacy and safety of intraarticular single cross linked Hyaluronan and platelet-rich plasma vs. PRP alone to treat knee osteoarthritis

Efficacy and safety of intraarticular single cross linked Hyaluronan and platelet-rich plasma vs. PRP alone to treat knee osteoarthritis Efficacy and safety of intraarticular single cross linked Hyaluronan and platelet-rich plasma vs. PRP alone to treat knee osteoarthritis
Efficacy and safety of intraarticular single cross linked Hyaluronan and platelet-rich plasma vs. PRP alone to treat knee osteoarthritis Efficacy and safety of intraarticular single cross linked Hyaluronan and platelet-rich plasma vs. PRP alone to treat knee osteoarthritis

A prospective randomized controlled trial was carried to explore the efficacy and safety of the combination of single cross-linked hyaluronan and a platelet-rich plasma compared to a single platelet-rich plasma alone in 85 individuals with knee osteoarthritis.

See All

Key take away

In patients with knee osteoarthritis, both combined injections of intraarticular single crosslinked Hyaluronan and platelet-rich plasma or a single platelet-rich plasma alone is safe and effective for six months. But the combination achieved better visual analog scale (VAS) pain reduction compared to a single platelet-rich plasma at six months.

Background

A prospective randomized controlled trial was carried to explore the efficacy and safety of the combination of single cross-linked hyaluronan and a platelet-rich plasma compared to a single platelet-rich plasma alone in 85 individuals with knee osteoarthritis.

Method

At each follow-up visit, substantial improvements were noted in VAS pain, SLS, WOMAC, and Lequesne index. Subjects treated with a single platelet-rich plasma witnessed higher improvements in VAS pain compared to subjects treated with combined injections at the one-month follow-up (Table.1).


At each follow-up visit, no vital between-group differences were noted in various secondary outcomes, except WOMAC-stiffness and WOMAC-pain scores supporting the one-injection group at one-month. However, the combined-injection cohort attained considerably better VAS pain decline at six-month follow-up. No severe adverse effects were observed after treatment in both study groups. 

Conclusion

Both combined injections of single cross-linked hyaluronan plus platelet-rich plasma and single platelet-rich plasma are favored for treating knee OA. 

Source:

Scientific Reports

Article:

Comparing efficacy of intraarticular single crosslinked Hyaluronan (HYAJOINT Plus) and platelet-rich plasma (PRP) versus PRP alone for treating knee osteoarthritis

Authors:

Shu-Fen Sun et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ua ru
Try: